---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-009028"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2024-03-06T23:59:59+00:00"
generated_at: "2026-06-05T02:38:52.091567+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Hepion appoints Michael Purcell to board as Audit Committee Chair

## Summary
- Michael Purcell appointed as director of Hepion Pharmaceuticals on March 5, 2024.
- Purcell named Chair of Audit Committee and member of Compensation and Corporate Governance/Nominations Committees.
- No departures reported; Purcell fills a board vacancy.
- Appointment effective immediately upon board vote.

## SEC filing metadata
- accession: 0001493152-24-009028
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2024-03-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315224009028/0001493152-24-009028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315224009028/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-009028
- JSON: https://secwatch.observer/filing/0001493152-24-009028.json
- Plain text: https://secwatch.observer/filing/0001493152-24-009028.txt

## Key facts
- Executive change
  Michael Purcell was appointed as Director at Hepion Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Director
  source text: On March 5, 2024, the Board of Directors of Hepion Pharmaceuticals, Inc. (the “Company”) appointed Michael Purcell as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583771/000149315224009028/0001493152-24-009028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.